Company Filing History:
Years Active: 2002-2007
Title: Innovations of Elizabeth A. Preisinger
Introduction
Elizabeth A. Preisinger is a notable inventor based in Roslindale, MA (US). She has made significant contributions to the field of biotechnology, particularly in the study of polypeptides and their aggregation properties. With a total of 2 patents, her work has implications for understanding and potentially treating neurodegenerative diseases.
Latest Patents
Preisinger's latest patents focus on nucleic acids encoding a polyglutamine fusion protein. These patents disclose methods for identifying compounds that disrupt the aggregation of aggregation-disposed polypeptides, such as huntingtin or beta-amyloid protein. Additionally, her patents describe an artificial polypeptide that contains an extended polyglutamine region, along with the DNA that encodes this polypeptide. These innovations are crucial for advancing research in neurodegenerative conditions.
Career Highlights
Elizabeth A. Preisinger is affiliated with the Massachusetts Institute of Technology, where she continues her research and development in biotechnology. Her work has garnered attention for its potential applications in medical science, particularly in the context of diseases characterized by protein aggregation.
Collaborations
Preisinger has collaborated with esteemed colleagues, including David E. Housman and Aleksey G. Kazantsev. These partnerships have enhanced her research efforts and contributed to the advancement of knowledge in her field.
Conclusion
Elizabeth A. Preisinger exemplifies the innovative spirit of modern inventors, with her work paving the way for future breakthroughs in biotechnology. Her contributions are vital for understanding complex biological processes and developing therapeutic strategies.